Skip to main content
Erschienen in: Virology Journal 1/2015

Open Access 01.12.2015 | Short report

Residues 41V and/or 210D in the NP protein enhance polymerase activities and potential replication of novel influenza (H7N9) viruses at low temperature

verfasst von: Wenfei Zhu, Xiaohui Zou, Jianfang Zhou, Jing Tang, Yuelong Shu

Erschienen in: Virology Journal | Ausgabe 1/2015

download
DOWNLOAD
print
DRUCKEN
insite
SUCHEN

Abstract

Background

The influenza A (H7N9) virus emerged in the spring of 2013 in China. It contained six internal genes from Y280-like H9N2 viruses, which have co-circulated with G1-like lineage viruses throughout poultry in China. Accompanied with continuous reassortment among H7N9 and H9N2 viruses in poultry, it is possible for H7N9 viruses to acquire internal genes of G1-lineage viruses. Thus, it is important to evaluate potential impact of G1-like viruses on the H7N9 viruses.

Findings

We used in vitro assays of polymerase activities and growth kinetics to evaluate the potential contribution of G1-like virus genes to the replication abilities of H7N9 viruses. Two mutations in the NP protein (41V and/or 210D) could enhance H7N9 RNP activities, especially at low temperature (33°C, which is similar to the temperature of human upper respiratory tract). Meanwhile, G1 viruses with V41I or D210E substitutions exhibited poor growth ability in the early infection stage at low temperature. The D210E substitution also reduced the replication ability of G1 virus at 12 and 24 hour post infection at 37°C. In both tested temperatures, V41I could compensate for the defective virus replication induced by the D210E mutation.

Conclusions

Mutations 41V and/or 210D in the NP protein conferred improved RNP activity in H7N9 viruses and promoted the replication ability of H9N2 viruses, particularly at lower temperature. Substitutions at these two positions may promote the replication ability of H7N9 viruses in low temperature and thus might contribute to viral transmissibility. While these two residues have not yet been observed in H7N9 viruses, attention should be devoted to these two residues.
Hinweise

Electronic supplementary material

The online version of this article (doi:10.​1186/​s12985-015-0304-6) contains supplementary material, which is available to authorized users.
Wenfei Zhu and Xiaohui Zou contributed equally to this work.

Competing interests

The authors declare that they have no competing interest.

Authors’ contributions

SYL designed the research; ZWF, ZXH, ZJF, and TJ performed research and analyzed data; ZWF wrote the paper; SYL revised the manuscript. All authors read and approved the final manuscript.
Abkürzungen
Gluc
Gaussia luciferase
RNP
Ribonucleoprotein
RdRp
Influenza RNA-dependent RNA polymerase
PB2
Polymerase basic 2 protein
PB1
Polymerase basic 1 protein
PA
Polymerase acidic protein
NP
Nucleoprotein
p.i.
post-infection
MDCK
Madin-Darby canine kidney

Findings

The zoonotic transmission of a novel influenza A (H7N9) virus into humans in February 2013 in Eastern China has become a global concern [1]. This H7N9 virus was a reassortant between H7 and N9 viruses, with six internal genes from Y280-lineage H9N2 avian influenza viruses. Although studies in avian and mammalian models such as chickens, pigs, ferrets, and non-human primates have shown that this virus is of low or mild pathogenicity [2-5], H7N9 infection in humans has often led to severe outcomes [1,6,7]. Glutamic acid (E)-to-lysine (K) substitution at position 627 in PB2, one of the important molecular markers of mammalian-adapted avian influenza viruses, was reported to be associated with enhanced virulence of the highly pathogenic H5N1 and H7N7 avian influenza viruses in mice [8,9], and responsible for viral replication at lower temperatures (33°C), allowing enhanced growth in the upper respiratory tract of mammals and efficient transmission of the viruses [10-13]. Although there has been limited human-to-human transmission [14], no highly transmissible cases have been reported for the novel H7N9 virus. This virus is reported to have more efficient replication in the lower respiratory tract than the upper respiratory tract [15], which merits studying the role of viral factors in transmissibility, especially viral replication at low temperature (33°C).
Multiple genotypes of H7N9 viruses have been reported via continuous reassortant of their internal genes with H9N2 viruses in poultry [16]. Additionally, two different H9N2 lineages, Y280-like and G1-like, co-circulate in poultry in mainland China [17-19], raising the possibility for H7N9 viruses to reassort with G1-like virus. To test whether four RNP complex genes (PB2, PB1, PA, and NP) of G1-like H9N2 viruses confer any advantages to those of H7N9 viruses, we first tested all recombinant RNP activities between A/Quail/Hong Kong/G1/1997 (H9N2, G1) and A/Anhui/1/2013 (H7N9, AH1) at 33°C and 37°C. Temperatures of 33°C and 37°C were used to approximate the conditions of human upper and lower respiratory tracts, respectively. Reporter plasmid polI-Gluc [20] was co-transfected with expression plasmids encoding PB2, PB1, PA, and the NP of G1 or AH1 into 293T cells using the PolyFect (Qiagen, Valencia, CA, USA) reagent, according to the manufacturer’s instructions. Gluc activity in supernatants was analyzed in 24 hours post transfection using a Gluc assay kit (New England Biolabs, Beverly, MA, USA) and normalized to AH1 RNP activity. G1 exhibited about 2.5-fold higher RNP activity than AH1 at 37°C (Figure 1B), while at 33°C the RNP of G1 showed much less activity than AH1 (Figure 1A). PB2-E627K could have contributed to the better RNP function of AH1 at 33°C, because the G1 virus contained the 627E residue at PB2 protein. In addition, the AH1-NP led to decreased RNP activity of G1 at 37°C, while the G1-NP enhanced the RNP activity of AH1 at both temperatures (Figure 1A, B).
For a more detailed investigation of the role of different NPs in viral replication and transcription, we constructed four NP plasmids from different subtype viruses: A/bar-headed goose/Qinghai/1/2005 (H5N1, QH1), A/Guangzhou/333/1999 (H9N2, GZ), A/California/04/2009 (2009pdmH1N1, CA04), and A/Puerto Rico/8/1934 (H1N1, PR8). We co-transfected polI-Gluc with plasmids expressing the RdRp subunits of AH1 plus different NPs into 293T cells, and RNP activities were tested. G1-NP was the only plasmid that significantly enhanced RNP activity of AH1 at 33°C (Figure 1C), and also increased RNP activity at 37°C about 1.25 fold (Figure 1D).
We then compared the sequences of the six tested NPs: AH1, G1, QH1, GZ, CA04, and PR8. G1-NP possessed two specific residues, 41V and 210D, while the other five NPs contained 41I and 210E (Additional file 1: Figure S1). To investigate whether the NP-41V and/or NP-210D mutations affect the enzymatic activity of RNPs, mutations NP-41V and/or NP-210D were introduced into the AH1-NP plasmid using a Site-Directed Mutagenesis Kit (Saibaisheng, Beijing, China). Conversely, mutations NP-41I and/or NP-210E were introduced into the G1-NP plasmid to generate mutant segments. The presence of the introduced mutation and the absence of additional unwanted mutations were verified by sequencing the entire plasmids. We then analyzed the activities of the recombinant RNP composed of AH1-PB2, AH1-PB1, AH1-PA, and various NPs (AH1-NP-WT, AH1-NP-I41V, AH1-NP-E210D, AH1-NP-I41V-E210D, G1-NP-WT, G1-NP-V41I, G1-NP-D210E, and G1-NP-V41I-D210E) in 293T cells at different temperatures using a mini-genome replication assay. Similar to the results exhibited in Figure 2, G1-NP-WT increased AH1-RNP activity at both 33°C and 37°C. Little effect was observed with G1-NP-V41I and/or G1-NP-D210E at 33°C, but reduced activity of V41I and D210E was shown at 37°C. Likewise, G1-NP with V41I and D210E decreased the G1-RNP-WT activities (Additional file 2: Figure S2). Moreover, AH1-NP with mutations I41V and/or E210D exhibited 5–20 fold increased RNP activity of AH1-WT at 33°C (Figure 2). These results indicate that residues 41V and 210D in NP proteins can enhance RNP activities of AH1 (H7N9), especially at 33°C.
To investigate the effect of NP-41V and/or 210D on virus replication, recombinant viruses were generated with reverse-genetics as described previously [21]. For biosafety concerns, the four rescued viruses were performed using G1 (H9N2) backbones: rgG1-WT, rgG1-NP-V41I, rgG1-D210E, and rgG1- NP-V41I-D210E. MDCK cells were infected with rescued viruses at a multiplicity of infection (MOI) of 0.001, and incubated in the appropriate medium containing 2 mg/L N-p-tosyl-L-phenylalaninechloromethyl ketone-treated (TPCK) trypsin (Sigma, Saint Louis, MO, USA) at 33 or 37°C. At 12, 24, 48, 72, and 96 hours post inoculation (hpi), supernatants were harvested and virus titers were determined using MDCK cells, as described previously [22]. As shown in Figure 3B, at 37°C, the D210E substitution in the NP protein significantly decreased the replication ability of rgG1-WT at early stages post infection (12 and 24 hpi (p < 0.05; n = 3), although all four viruses demonstrated comparable growth capability at later stages. Mutation NP-V41I alone or in combination with D210E, which showed decreased polymerase activity, exhibited little impact on the growth of rescued virus at 37°C. The apparent discrepancy between the minigenome reporter assay and the in vitro virus replication assay in our study may be related to the different parameters; whereas mRNA synthesis and reporter protein expression is the primary readout in minigenome assays, for efficient virus replication, a proper balance between the syntheses of cRNA, vRNA, and mRNA is required. However, at 33°C, G1 viruses with the D210E mutation displayed a replication defect (Figure 3A). The rgG1-WT virus demonstrated better replication ability to the other three viruses, except G1-NP-V41I of 72 hpi. These data indicate a growth advantage of recombinant viruses of rgG1-WT containing NP-41V and NP-210D in MDCK cells at 33°C, which corresponds to their high polymerase activity in 293T cells.
Sequence alignment of available NP sequences of avian and mammalian influenza A viruses in NCBI showed that in 14,142 NP sequences, 357 (2.5%) possess NP-41V and 156 (1.1%) possess NP-210D (Table 1). Most of the viruses with NP-41V or NP-210D residues were avian influenza viruses (197/357 and 143/156, respectively). However, few NP-41V or NP-210D residues were found in mammalian influenza viruses, including those of human and swine-origin viruses. In addition, no such substitutions have yet been found in the novel H7N9 viruses (data not shown). Despite this, our study revealed that compared with NP-210D, NP-210E could reduce the RNP activity of AH1 (H7N9) and G1 (H9N2) viruses, and could also inhibit the replication of G1 viruses, especially at 33°C. However, compared with NP-41V, although viruses with NP-41I were associated with decreased RNP activity, no significant variation in virus growth ability was observed. Therefore, mutations NP-41V and/or NP-210D may increase the growth capability of the AH1 (H7N9) virus, particularly in low temperature. Reassortants between G1-like and Y280-like viruses are not rare [17-19]. Given the continuous mutation and dynamic reassortment [16,23] of H7N9 viruses in both human and avian hosts, the possibility for these viruses to obtain these two residues or the entire NP gene of G1-like viruses cannot be excluded. Therefore, despite the absence of amino acids 41V and 201D in the NP of current H7N9 viruses, reassortants with the entire G1-like NP gene and substitutions of these two residues in the NP protein are worthy of attention.
Table 1
Database search for NP-41I/V and/or NP-210D/E mutations in virus isolates from nature
Mutations
Human
Swine
Avian
Canine
Equine
Other residues
NP-41V
6
14
197
42
98
I(13,763), A(2), G(3), K(1), M(1), Q(8), T(6), Y(1)
(n = 357)
NP-210D
9
4
143
0
0
E(13960), G(2), N(9), P(3), Q(2), R(3), X(7)
(n = 156)
NP-41V + 210D
6
0
19
0
0
(n = 25)
The data shown are the number of sequences with identical amino acid composition (NP-41 and NP-210) of 14,142 influenza isolates in the NCBI database. The total number of each residue is shown in parentheses.

Acknowledgements

This study was supported by the National Nature Science Foundation of China (81341003) and the National Mega-projects for Infectious Diseases (2014ZX10004002).
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made.
The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder.
The Creative Commons Public Domain Dedication waiver (https://​creativecommons.​org/​publicdomain/​zero/​1.​0/​) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Competing interests

The authors declare that they have no competing interest.

Authors’ contributions

SYL designed the research; ZWF, ZXH, ZJF, and TJ performed research and analyzed data; ZWF wrote the paper; SYL revised the manuscript. All authors read and approved the final manuscript.
Literatur
1.
Zurück zum Zitat Gao R, Cao B, Hu Y, Feng Z, Wang D, Hu W, et al. Human infection with a novel avian-origin influenza A (H7N9) virus. N Engl J Med. 2013;368:1888–97.CrossRefPubMed Gao R, Cao B, Hu Y, Feng Z, Wang D, Hu W, et al. Human infection with a novel avian-origin influenza A (H7N9) virus. N Engl J Med. 2013;368:1888–97.CrossRefPubMed
2.
Zurück zum Zitat Zhu H, Wang D, Kelvin DJ, Li L, Zheng Z, Yoon SW, et al. Infectivity, transmission, and pathology of human-isolated H7N9 influenza virus in ferrets and pigs. Science. 2013;341:183–6.CrossRefPubMed Zhu H, Wang D, Kelvin DJ, Li L, Zheng Z, Yoon SW, et al. Infectivity, transmission, and pathology of human-isolated H7N9 influenza virus in ferrets and pigs. Science. 2013;341:183–6.CrossRefPubMed
3.
Zurück zum Zitat Zhang Q, Shi J, Deng G, Guo J, Zeng X, He X, et al. H7N9 influenza viruses are transmissible in ferrets by respiratory droplet. Science. 2013;341:410–4.CrossRefPubMed Zhang Q, Shi J, Deng G, Guo J, Zeng X, He X, et al. H7N9 influenza viruses are transmissible in ferrets by respiratory droplet. Science. 2013;341:410–4.CrossRefPubMed
4.
Zurück zum Zitat Watanabe T, Kiso M, Fukuyama S, Nakajima N, Imai M, Yamada S, et al. Characterization of H7N9 influenza A viruses isolated from humans. Nature. 2013;501:551–5.CrossRefPubMedCentralPubMed Watanabe T, Kiso M, Fukuyama S, Nakajima N, Imai M, Yamada S, et al. Characterization of H7N9 influenza A viruses isolated from humans. Nature. 2013;501:551–5.CrossRefPubMedCentralPubMed
5.
Zurück zum Zitat Belser JA, Gustin KM, Pearce MB, Maines TR, Zeng H, Pappas C, et al. Pathogenesis and transmission of avian influenza A (H7N9) virus in ferrets and mice. Nature. 2013;501:556–9.CrossRefPubMed Belser JA, Gustin KM, Pearce MB, Maines TR, Zeng H, Pappas C, et al. Pathogenesis and transmission of avian influenza A (H7N9) virus in ferrets and mice. Nature. 2013;501:556–9.CrossRefPubMed
6.
Zurück zum Zitat Li Q, Zhou L, Zhou M, Chen Z, Li F, Wu H, et al. Preliminary Report: Epidemiology of the Avian Influenza A (H7N9) Outbreak in China. N Engl J Med. 2013;370:520–32.CrossRefPubMed Li Q, Zhou L, Zhou M, Chen Z, Li F, Wu H, et al. Preliminary Report: Epidemiology of the Avian Influenza A (H7N9) Outbreak in China. N Engl J Med. 2013;370:520–32.CrossRefPubMed
7.
Zurück zum Zitat Gao HN, Lu HZ, Cao B, Du B, Shang H, Gan JH, et al. Clinical findings in 111 cases of influenza A (H7N9) virus infection. N Engl J Med. 2013;368:2277–85.CrossRefPubMed Gao HN, Lu HZ, Cao B, Du B, Shang H, Gan JH, et al. Clinical findings in 111 cases of influenza A (H7N9) virus infection. N Engl J Med. 2013;368:2277–85.CrossRefPubMed
8.
Zurück zum Zitat Hatta M, Gao P, Halfmann P, Kawaoka Y. Molecular basis for high virulence of Hong Kong H5N1 influenza A viruses. Science. 2001;293:1840–2.CrossRefPubMed Hatta M, Gao P, Halfmann P, Kawaoka Y. Molecular basis for high virulence of Hong Kong H5N1 influenza A viruses. Science. 2001;293:1840–2.CrossRefPubMed
9.
Zurück zum Zitat Labadie K, Dos Santos AE, Rameix-Welti MA, van der Werf S, Naffakh N. Host-range determinants on the PB2 protein of influenza A viruses control the interaction between the viral polymerase and nucleoprotein in human cells. Virology. 2007;362:271–82.CrossRefPubMed Labadie K, Dos Santos AE, Rameix-Welti MA, van der Werf S, Naffakh N. Host-range determinants on the PB2 protein of influenza A viruses control the interaction between the viral polymerase and nucleoprotein in human cells. Virology. 2007;362:271–82.CrossRefPubMed
10.
Zurück zum Zitat Hatta M, Hatta Y, Kim JH, Watanabe S, Shinya K, Nguyen T, et al. Growth of H5N1 influenza A viruses in the upper respiratory tracts of mice. PLoS Pathog. 2007;3:1374–9.CrossRefPubMed Hatta M, Hatta Y, Kim JH, Watanabe S, Shinya K, Nguyen T, et al. Growth of H5N1 influenza A viruses in the upper respiratory tracts of mice. PLoS Pathog. 2007;3:1374–9.CrossRefPubMed
11.
Zurück zum Zitat Massin P, van der Werf S, Naffakh N. Residue 627 of PB2 is a determinant of cold sensitivity in RNA replication of avian influenza viruses. J Virol. 2001;75:5398–404.CrossRefPubMedCentralPubMed Massin P, van der Werf S, Naffakh N. Residue 627 of PB2 is a determinant of cold sensitivity in RNA replication of avian influenza viruses. J Virol. 2001;75:5398–404.CrossRefPubMedCentralPubMed
12.
Zurück zum Zitat Steel J, Lowen AC, Mubareka S, Palese P. Transmission of influenza virus in a mammalian host is increased by PB2 amino acids 627 K or 627E/701 N. PLoS Pathog. 2009;5:e1000252.CrossRefPubMedCentralPubMed Steel J, Lowen AC, Mubareka S, Palese P. Transmission of influenza virus in a mammalian host is increased by PB2 amino acids 627 K or 627E/701 N. PLoS Pathog. 2009;5:e1000252.CrossRefPubMedCentralPubMed
13.
Zurück zum Zitat Van Hoeven N, Pappas C, Belser JA, Maines TR, Zeng H, Garcia-Sastre A, et al. Human HA and polymerase subunit PB2 proteins confer transmission of an avian influenza virus through the air. Proc Natl Acad Sci U S A. 2009;106:3366–71.CrossRefPubMedCentralPubMed Van Hoeven N, Pappas C, Belser JA, Maines TR, Zeng H, Garcia-Sastre A, et al. Human HA and polymerase subunit PB2 proteins confer transmission of an avian influenza virus through the air. Proc Natl Acad Sci U S A. 2009;106:3366–71.CrossRefPubMedCentralPubMed
14.
Zurück zum Zitat Qi X, Qian YH, Bao CJ, Guo XL, Cui LB, Tang FY, et al. Probable person to person transmission of novel avian influenza A (H7N9) virus in Eastern China, 2013: epidemiological investigation. BMJ. 2013;347:f4752.CrossRefPubMedCentralPubMed Qi X, Qian YH, Bao CJ, Guo XL, Cui LB, Tang FY, et al. Probable person to person transmission of novel avian influenza A (H7N9) virus in Eastern China, 2013: epidemiological investigation. BMJ. 2013;347:f4752.CrossRefPubMedCentralPubMed
15.
Zurück zum Zitat Zhou J, Wang D, Gao R, Zhao B, Song J, Qi X, et al. Biological features of novel avian influenza A (H7N9) virus. Nature. 2013;499:500–3.CrossRefPubMed Zhou J, Wang D, Gao R, Zhao B, Song J, Qi X, et al. Biological features of novel avian influenza A (H7N9) virus. Nature. 2013;499:500–3.CrossRefPubMed
16.
Zurück zum Zitat Wang D, Yang L, Gao R, Zhang X, Tan Y, Wu A, et al. Genetic tuning of the novel avian influenza A(H7N9) virus during interspecies transmission, China, 2013. Euro Surveill. 2014; 19(25). Wang D, Yang L, Gao R, Zhang X, Tan Y, Wu A, et al. Genetic tuning of the novel avian influenza A(H7N9) virus during interspecies transmission, China, 2013. Euro Surveill. 2014; 19(25).
17.
Zurück zum Zitat Zhang P, Tang Y, Liu X, Liu W, Zhang X, Liu H, et al. A novel genotype H9N2 influenza virus possessing human H5N1 internal genomes has been circulating in poultry in eastern China since 1998. J Virol. 2009;83:8428–38.CrossRefPubMedCentralPubMed Zhang P, Tang Y, Liu X, Liu W, Zhang X, Liu H, et al. A novel genotype H9N2 influenza virus possessing human H5N1 internal genomes has been circulating in poultry in eastern China since 1998. J Virol. 2009;83:8428–38.CrossRefPubMedCentralPubMed
18.
Zurück zum Zitat Li C, Yu K, Tian G, Yu D, Liu L, Jing B, et al. Evolution of H9N2 influenza viruses from domestic poultry in Mainland China. Virology. 2005;340:70–83.CrossRefPubMed Li C, Yu K, Tian G, Yu D, Liu L, Jing B, et al. Evolution of H9N2 influenza viruses from domestic poultry in Mainland China. Virology. 2005;340:70–83.CrossRefPubMed
19.
Zurück zum Zitat Li KS, Xu KM, Peiris JS, Poon LL, Yu KZ, Yuen KY, et al. Characterization of H9 subtype influenza viruses from the ducks of southern China: a candidate for the next influenza pandemic in humans? J Virol. 2003;77:6988–94.CrossRefPubMedCentralPubMed Li KS, Xu KM, Peiris JS, Poon LL, Yu KZ, Yuen KY, et al. Characterization of H9 subtype influenza viruses from the ducks of southern China: a candidate for the next influenza pandemic in humans? J Virol. 2003;77:6988–94.CrossRefPubMedCentralPubMed
20.
Zurück zum Zitat Zhu W, Zhou J, Qin K, Du N, Liu L, Yu Z, et al. A reporter system for assaying influenza virus RNP functionality based on secreted Gaussia luciferase activity. Virol J. 2011;8:29.CrossRefPubMedCentralPubMed Zhu W, Zhou J, Qin K, Du N, Liu L, Yu Z, et al. A reporter system for assaying influenza virus RNP functionality based on secreted Gaussia luciferase activity. Virol J. 2011;8:29.CrossRefPubMedCentralPubMed
21.
Zurück zum Zitat Fodor EDL, Engelhardt OG, Palese P, Brownlee GG, García-Sastre A. Rescue of influenza A virus from recombinant DNA. J Virol. 1999;73:9679–82.PubMedCentralPubMed Fodor EDL, Engelhardt OG, Palese P, Brownlee GG, García-Sastre A. Rescue of influenza A virus from recombinant DNA. J Virol. 1999;73:9679–82.PubMedCentralPubMed
22.
Zurück zum Zitat Reed LJM. H. A simple method of estimating fifty percent endpoints. Am J Hyg. 1938;27:493–7. Reed LJM. H. A simple method of estimating fifty percent endpoints. Am J Hyg. 1938;27:493–7.
23.
Zurück zum Zitat Zhu W, Shu Y. Genetic tuning of avian influenza A (H7N9) virus promotes viral fitness within different species. Microbes Infect. 2014;17(2):118–22.CrossRefPubMed Zhu W, Shu Y. Genetic tuning of avian influenza A (H7N9) virus promotes viral fitness within different species. Microbes Infect. 2014;17(2):118–22.CrossRefPubMed
Metadaten
Titel
Residues 41V and/or 210D in the NP protein enhance polymerase activities and potential replication of novel influenza (H7N9) viruses at low temperature
verfasst von
Wenfei Zhu
Xiaohui Zou
Jianfang Zhou
Jing Tang
Yuelong Shu
Publikationsdatum
01.12.2015
Verlag
BioMed Central
Erschienen in
Virology Journal / Ausgabe 1/2015
Elektronische ISSN: 1743-422X
DOI
https://doi.org/10.1186/s12985-015-0304-6

Weitere Artikel der Ausgabe 1/2015

Virology Journal 1/2015 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.